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ABSTRACT
Objective: To review a sample of cluster randomised
controlled trials and explore the quality of reporting of
(1) enabling or support activities provided to the staff
during the trial, (2) strategies used to monitor fidelity
throughout the trial and (3) the extent to which the
intervention being tested was delivered as planned.
Design: A descriptive review.
Data sources and study selection: We searched
MEDLINE for trial reports published between 2008 and
2014 with combinations of the search terms
‘randomised’, ‘cluster’, ‘trial’, ‘study’, ‘intervention’ and
‘implement*’. We included trials in which healthcare
professionals (HCPs) implemented the intervention
being tested as part of routine practice. We excluded
trials (1) conducted in non-health services settings, (2)
where the intervention explicitly aimed to change the
behaviours of the HCPs and (3) where the trials were
ongoing or for which only trial protocols were
available.
Data collection: We developed a data extraction form
using the Template for Intervention Description and
Replication (TIDieR checklist). Review authors
independently extracted data from the included trials
and assessed quality of reporting for individual items.
Results: We included 70 publications (45 results
publications, 25 related publications). 89% of trials
reported using enabling or support activities. How
these activities were provided (75.6%, n=34) and how
much was provided (73.3%, n=33) were the most
frequently reported items. Less than 20% (n=8) of the
included trials reported that competency checking
occurred prior to implementation and data collection.
64% (n=29) of trials reported collecting measures of
implementation. 44% (n=20) of trials reported data
from these measures.
Conclusions: Although enabling and support
activities are reported in trials, important gaps exist
when assessed using an established checklist. Better
reporting of the supports provided in effectiveness
trials will allow for informed decisions to be made
about financial and resource implications for wide
scale implementation of effective interventions.
INTRODUCTION
A seminal publication in 2009 by Chalmers
and Glasziou1 identiﬁed unusable research
reports as a primary contributor to avoidable
waste in research production. Despite compre-
hensive guidelines to assist with the reporting
of clinical trials, for example the Consolidated
Standards of Reporting Trials (CONSORT)
2010 statement2 and the Standard Protocol
Items: Recommendations for Interventional
Trials (SPIRIT) 2013 statement,3 gaps in the
completeness of reports remain. Trials of
complex non-pharmacological interventions
have proved a particular challenge. Complex
Strengths and limitations of this study
▪ Enabling or support activities used to facilitate
implementation of interventions in effectiveness
trials should be described in sufficient detail to
allow interpretation of results and future
replication.
▪ In this study we used a published checklist,
TIDieR (the Template for Intervention Description
and Replication), to comprehensively assess the
quality of reporting of enabling or support activ-
ities in cluster randomised trials.
▪ We did not rate the quality of reporting, as other
studies have, but assessed whether or not
authors reported details for items of the TIDieR
checklist. The figures provided here may there-
fore present a more positive picture than would
be the case if we assessed the extent to which
interventions could be replicated from the details
provided.
▪ Our search strategy was designed to identify a
sample of effectiveness trials conducted in
health services settings and a large number of
eligible published trials may not have been iden-
tified potentially limiting the generalisability of
the results.
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interventions are those with numerous interacting compo-
nents and have been found to be adequately described in
only 39% of trials.4
Randomised controlled trials (RCTs) have traditionally
been designed to demonstrate the efﬁcacy of complex
interventions under optimum conditions.5 However,
numerous challenges exist in attempting to translate
research evidence from efﬁcacy trials into real-life clinical
practice. Most notably the lack of external validity, or gen-
eralisability, which has been a long-standing criticism of
the RCT methodology.6 To address this issue, there has
been a dramatic increase in the number of effectiveness
trials being conducted which explore the degree of beneﬁ-
cial effect of interventions when delivered under real
world conditions.7 RCTs are not considered to be either
efﬁcacy or effectiveness trials but can have characteristics
of both and thus are said to sit on a continuum.8
As a result of the growing interest in more pragmatic
trial designs, we have also seen an increase in the use of
cluster randomisation in health services research (ie,
where groups of patients, rather than individual patients,
are randomised). Cluster randomised designs are particu-
larly appropriate when there is a risk of contamination
across trial groups when trial patients are managed within
the same setting.9 Pragmatic cluster randomised trials will
usually evaluate interventions when they are delivered by
routinely employed healthcare professionals. Successful
implementation therefore requires a change in the prac-
tices of these professionals.10 The ‘CONSORT’ extension
for the reporting of RCTs of non-pharmacological treat-
ments11 and the Template for Intervention Description
and Replication (TIDieR) checklist,12 prompt authors to
report on any activities that are used to enable or support
professionals to implement the interventions being tested,
and to report actual implementation of the intervention.
These enabling or support activities can be considered to
be interventions in themselves and therefore merit equal
description in trial reports.
Previous studies exploring the completeness of inter-
vention descriptions in clinical trials have not differen-
tiated between different trial designs and have not
explicitly assessed the completeness of reporting of
enabling or support activities used to assist professionals
in implementing the interventions being tested.4 13–15 In
this study we reviewed a sample of cluster RCTs, in
which healthcare professionals employed to routinely
deliver care were responsible for implementing the
interventions being tested. We explored the quality of
reporting of (1) enabling or support activities provided
during the trial, (2) strategies used to monitor ﬁdelity
throughout the trial and (3) the extent to which the
intervention was delivered as planned.
METHODS
Search strategy and selection of reports of trials
To identify a sample of trial reports for the review we
searched MEDLINE for publications with combinations
of the search terms ‘randomised’, ‘cluster’, ‘trial’,
‘study’, ‘intervention’ and ‘implement*’ in their titles or
abstracts (see online supplementary ﬁle S1). To manage
the scope of the review we included reports of cluster
RCTs published between 2008 and 2014. This date
range was chosen as the Medical Research Council
(MRC) guidance on developing and evaluating complex
interventions was published in 2008,10 a seminal publica-
tion which has inﬂuenced the quality of reporting in
trials of complex interventions. We included trials,
accessible online and published in English, in which
healthcare professionals (HCPs) implemented the
intervention being tested as part of their routine prac-
tice. We excluded trials (1) conducted in non-health
services settings (eg, schools, universities), (2) where the
intervention being tested explicitly aimed to change the
behaviours of the HCPs (eg, behaviour change interven-
tions (BCIs) such as screening tools, decision aids, audit
and feedback) and (3) if the trials were ongoing or for
which only trial protocols were available. In instances
where the intervention being tested served a dual
purpose of impacting on patient outcomes, and also
changing the behaviours of healthcare professionals to
implement best practice, we made decisions on a
case-by-case basis. Trials were included in which health-
care professionals were responsible for implementing
deﬁned actions or components of the interventions
being tested. Where it was not possible to identify
deﬁned actions or components of the interventions to
be implemented these trials were excluded.
NM conducted the ﬁrst round of screening to remove
irrelevant trials based on the exclusion criteria. In pairs,
all authors independently screened the titles and
abstracts of the remaining trials for inclusion.
Discrepancies were resolved by discussion or by a third
party. In instances where it was not possible to exclude
trials based on title and abstract, full-text versions were
obtained and were assessed for inclusion by the authors
in the same way. Relevant publications related to the
included trials (ie, trial protocols, process evaluations)
were identiﬁed where possible by using the trial registra-
tion number or by manually searching for publications
where the primary investigator named on the trial regis-
tration was an author.
Data extraction and analysis
A data extraction form, based on the TIDieR checklist,12
was developed for the purposes of the review. All of the
TIDieR items were applied to enabling and support
activities. Data on ﬁdelity was extracted at two levels (1)
ﬁdelity of implementation of the enabling and support
activities and (2) ﬁdelity of implementation of the inter-
vention being tested. Throughout data extraction we
made minor iterative changes to the way in which the
items of the TIDieR checklist were organised to facilitate
ease of use. For example, we reordered some of the
items to ﬁt with how they most often appeared in
publications, and we separated ‘when’ and ‘how much’.
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Some additional information highlighted in the TIDieR
checklist publication was coded as a separate item as it
was reported in a number of trials (ie, competency
checking is discussed under ‘who provided’ in the ori-
ginal TIDieR publication and we extracted this as a
stand-alone item). The ﬁnal data extraction form is pro-
vided in online supplementary ﬁle S2. Data were
extracted on: the rationale for the support or enabling
activities, materials and procedures used, where the
activities were delivered, by who, when and how often
and if the training was accredited or competency
checked. Data on tailoring or modiﬁcations to the activ-
ities were extracted along with planned strategies to
monitor implementation ﬁdelity, and actual implementa-
tion of the intervention during the trial. Three pairs of
authors independently extracted data from 15 trials
each, where one author (NM) was a member of two
pairs. Extracted data were cross-checked in the pairs and
ﬁndings were discussed until consensus for each section
was reached and the authors agreed that all potentially
relevant information had been extracted.
Previous studies have rated intervention descriptions
as adequate/complete or inadequate/incomplete.4 14
Owing to the subjective nature of these types of ratings
(ie, there is not yet consensus as to what information
must be reported in what level of detail to constitute an
adequate description of an intervention) it was decided
by the study team to assess each section of the TIDieR
checklist as ‘reported’ or ‘not reported’, and where
information was reported to extract examples of more
detailed reporting and more typical reporting. Items
were assessed as ‘not reported’ if there was no mention
of that item at all in the trial publications. Where
authors made any reference to an item it was assessed as
‘reported’. A limitation of this approach to assessment is
that it may overstate the quality of reporting in included
studies. All authors independently reviewed the
extracted data for each trial and made an assessment for
each item extracted. Examples of variation in reporting
were also highlighted by each of the review authors at
this stage. Cross-checking of the assessments was carried
out by the lead author. Microsoft Excel was used to
analyse the data descriptively.
RESULTS
We identiﬁed 630 citations from our initial search. This
became 563 when duplicate citations were removed.
Trials that were conducted in a non-health service
setting were excluded in the ﬁrst round of screening
(n=240) and the eligibility criteria applied to the
remaining 323 citations. A total of 70 citations were
included for data extraction (45 trial results publications
and 25 related publications). Where available we used
trial registration numbers to identify publications that
may have been relevant for data extraction. We identi-
ﬁed trial registration numbers for 35 of the 45 included
trials. Known trial registration numbers were used to
search PubMed identifying protocols and trial results
publications for 26 of the included trials. The remaining
publications could not be retrieved using the trial regis-
tration number alone. Identiﬁcation of related publica-
tions through trial registration number search was not
always successful but searching using a combination of
author name, trial name and keywords identiﬁed seven
additional process evaluation publications. For the 35
trials with registration numbers, 16 registrations had no
records of publications, six had a results publication but
no protocol, 12 had both the protocol and results publi-
cations and one was not in English. Related publications
for the nine trials where registration numbers were not
identiﬁed were retrieved through additional manual
searching. In all but one of the related publications
there was an obvious link to the original trial, that is, the
trial was named or cited in the publication. One poten-
tially related publication was not included as it was not
possible to link the content to the original trial.16 A ﬂow
diagram of studies through the review is provided in
ﬁgure 1. Citations excluded as ‘not relevant’ were sec-
ondary trial publications (eg, cost-effectiveness publica-
tions), trials where the healthcare professionals
employed to deliver routine care did not take an active
role in implementing an intervention (eg, system-wide
quality improvement) and trials where healthcare
Figure 1 PRISMA flow diagram (BCI, behaviour change
intervention; HCP, healthcare professional).
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professionals were recipients of an education or training
intervention (eg, train-the-trainer initiative). All publica-
tions included in data extraction are provided in online
supplementary ﬁle S3.
Characteristics of included trials
The trials included in the review span 22 countries. The
country with the most included trials was the
Netherlands (n=7), followed by Australia (n=5), Spain
(n=5) and the UK (n=5). The trial results publications
came from 33 different journals including the BMJ
(n=5), PLoS One (n=4) and the Lancet (n=3). The condi-
tions most frequently studied were type 2 diabetes (n=5),
asthma (n=4), cardiovascular disease, hypertension and
stroke (n=4) and maternal and child health (n=4). Over
half of the trials were conducted in primary care settings
(n=23) and primarily evaluated lifestyle/self-
management interventions (n=22). Nurses were respon-
sible for implementing the intervention in 12 trials,
general practitioners in 10 and pharmacists in 4. Further
details on the characteristics of the included studies are
provided in online supplementary ﬁle S4.
Quality of reporting of enabling or support activities
Forty of the 45 trials (88.8%) made reference to some
form of enabling or support activities conducted during
the trial. Of the ﬁve trials that did not describe any
enabling or support activities, three of these were evalu-
ating infection control interventions in hospital settings.
The number of trials providing information on each of
the items of the TIDieR checklist, adapted for enabling
or support activities, is shown in table 1. How activities
were provided, and how much, were the most frequently
reported items (75.6% and 73.3% of trials, respectively).
Reporting of the rationale for the chosen activities, any
tailoring or modiﬁcations of the activities and measures
of planned and actual activities carried out during the
trial (eg, attendance at training sessions) were the least
frequently reported.
Quality of reporting of strategies used to monitor fidelity
throughout the trial and the extent to which the
intervention was delivered as planned
Over half of the included trials (n=29) reported moni-
toring the extent to which healthcare professionals
delivered the intervention as planned within the trial.
The ways in which ﬁdelity was most frequently moni-
tored included notes audits (n=12), rating of random
samples of audio-recorded sessions (n=5), self-reported
measures of implementation (from healthcare profes-
sionals and study participants) (n=4) and observation of
practice (n=2). Of the trials that reported collecting
measures of ﬁdelity, data from these measures was
reported in 44.4% (n=20) of the trials. Examples of
reporting, and variation across trials for the individual
items are provided in online supplementary ﬁle S5.
DISCUSSION
Statement of principal findings
Almost all of the trials (89%) included in this review
reported that enabling or support activities were used to
facilitate implementation of the intervention being
tested. However, large discrepancies were identiﬁed in
the quality of reporting of the components of these
activities. Authors most frequently reported how enab-
ling or support activities were provided, and how much
was provided, but details related to who provided, where,
when and the underpinning rationale for the content
and delivery of the activities were often omitted. Less
than 20% of the included trials reported that compe-
tency checking took place prior to implementation and
data collection. Although, 29 trials reported using spe-
ciﬁc ﬁdelity measures to assess the extent to which the
healthcare professionals had implemented the interven-
tion as planned during the trial, data from these mea-
sures was not reported in nine instances.
Strengths and weaknesses of the study
A strength of this study is the use of the published TIDieR
checklist (the Template for Intervention Description and
Replication) to assess the quality of reporting of the
included trials.12 TIDieR has been developed by
Hoffmann and colleagues as an extension to Item 5 of the
CONSORT Statement and aims to guide authors in
describing interventions in a level of detail to allow for
future replication. Although the primary purpose of the
TIDieR checklist is to assist in the describing of interven-
tions being tested, a number of items in TIDieR discuss
how some interventions, particularly complex ones, might
require additional activities to enable or support the inter-
vention to occur, and these should also be described. We
would argue, and have demonstrated here, that these activ-
ities are interventions in themselves and therefore can be
reported with the same level of detail and attention
afforded to the intervention under investigation.
A limitation of this review may be the included trials
and the way in which they were identiﬁed. Although a
Table 1 Number of trials reporting components of
enabling or support activities
Components of enabling or support
activities
Reported
Per cent n
Why 11.1 5
Who provided 53.3 24
What materials 57.8 26
Where 22.2 10
When 51.1 23
How 75.6 34
How much 73.3 33
Tailoring 4.4 2
Modifications 4.4 2
Measure of fidelity 2.2 1
Actual activities delivered 6.7 3
Competency checking 17.8 8
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systematic process was used to identify effectiveness
cluster RCTs, a large number of published trials will not
have been identiﬁed by our search (eg, due to the time
period or search terms used). The results of our review
therefore may not be generalisable. However, it is also
unknown whether a larger sample would have inﬂu-
enced the overall results of the study. When attempting
to identify secondary publications for the included trials
it became evident that authors do not always include the
trial registration numbers in the trial results publica-
tions. We carried out additional searching using publica-
tion titles, trial names and author names but were
unable to locate trial registration numbers for 10 of the
included trials. It is not possible to conclude whether
these trials were not registered or whether the search
efforts were unable to locate registration details. We
endeavoured to retrieve all relevant publications, includ-
ing process evaluations and reports on training proce-
dures. However, it is possible that details of support
activities may be reported in publications not identiﬁed
during our searches. It was interesting to note that in a
number of instances process evaluation publications did
not provide additional information on actual implemen-
tation during the trial or associated measures. The focus
of these publications was often on providing in depth
qualitative accounts on stakeholders experiences of the
implementation process. MRC guidance on process
evaluations was published earlier this year and may
result in greater consistency as to the type of information
reported in these evaluations.17
As previously mentioned, similar trials4 13 14 have not
only looked at whether or not details have been
reported but have also made a judgement as to whether
the details provided were sufﬁcient to merit replication.
In this review we opted to assess whether or not authors
provided details on the items of the TIDieR checklist
and provide supporting examples. This may also be a
limitation of the review as the ﬁgures provided here
without doubt present a more positive picture than
would be the case if we were to make subjective judge-
ments on the extent to which interventions could be
replicated from the details provided.
Meaning of the study
Despite improvements in the quality of reporting of clin-
ical research in recent years, complex trial designs and
interventions have resulted in trial reports leaving
readers with many questions unanswered. In this review
we have focused in particular on the reporting of enab-
ling and support activities and implementation ﬁdelity
within trials, as this is important information for both
interpreting the research ﬁndings and also for clinicians
wanting guidance on how to implement interventions in
their practice. We have shown that although these activ-
ities are reported in trials, there exist important gaps
when assessed using items of the TIDieR checklist.
Implementation science is a growing ﬁeld of research,
with much interest in how we can best translate
interventions that have been shown to be effective in
research into day-to-day clinical practice. In order to pro-
gress this ﬁeld of research it is important that authors
describe the rationale for their implementation activ-
ities, and the components of these activities in order to
contribute to the growing evidence base. Publication
restrictions pose a particular challenge in achieving this
goal and therefore novel methods of efﬁciently commu-
nicating these details in useable formats are urgently
needed.
Unanswered questions and future research
Effectiveness cluster randomised trials of complex non-
pharmacological interventions pose numerous chal-
lenges in their design, implementation and reporting.
However, there is a growing appreciation for the
nuanced and iterative processes that occur when intro-
ducing a new intervention into routine clinical practice
and the role of contextual and personal factors.18 There
is a need for more transparent reporting about what is
happening in trials to make informed decisions about
the feasibility and effectiveness of interventions, along
with their likely ﬁnancial and resource implications.
There is also a need to establish consensus about the
level of detail that should be reported for such large
scale trials to ensure that what is reported is meaningful
and useful for patients, the public, clinicians and
researchers.
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